Science Market Update

NY Scientists Awarded $3.1M for HIV Vaccine Research

Posted by Laura Braden on Tue, Nov 10, 2015

The University of Rochester, New YorkSince its emergence in the 1980's, HIV/AIDS has been a prominent point of research for life scientists around the world. With no current cure or vaccine available, scientists receive substantial amounts of funding to study this virus to gain a better understanding of it as well as to produce a vaccine that will combat the virus better than current treatments do, which can only slow and control the virus, but not cure it.

Read More

Tags: Northeast, HIV, infectious diseases, New York, Rochester, BioResearch Product Faire Event, NY, 2016, University of Rochester, URoch, HIV Vaccine, B Cells

Subscribe to Company News